Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Winners: Digital Health Companies Noom, Akili, Hello Heart Scored New Funding

Executive Summary

Akili Interactive, Hello Heart and Noom announced new funding rounds today, proving that investors’ strong appetite for companies that are part of the digital transformation in health care.

You may also be interested in...



Akili Pays $37.5M To License Tali’s Tech For Early Childhood Attention Impairments

Tali’s video game assesses and improves attention in children three to eight years old. Akili markets the EndeavorRx prescription video game therapy to improve attention function in children ages eight to 12. The deal will help Tali commercialize its technology in the US.

Kaia Health Publishes Study Showing Digital Physical Therapy Corrections On Par With Human Therapist

Kaia Health published a study suggesting its digital physical therapy is not inferior to seeing a physiotherapist. Digital app makers focusing on rehabilitating musculoskeletal conditions have seen significant growth during the pandemic.

Happify Health Launches Prescription Digital Therapeutics To Treat Depression Or Anxiety

After raising $73m in a series D in March, Happify Health is recruiting patients in a real-world study to further evaluate its behavioral health app.

Related Content

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

MT143984

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel